Yüklüyor......
Co-inhibition of SMAD and MAPK signaling enhances (124)I uptake in BRAF-mutant thyroid cancers
Constitutive MAPK activation silences genes required for iodide uptake and thyroid hormone biosynthesis in thyroid follicular cells. Accordingly, most BRAF(V600E) papillary thyroid cancers (PTC) are refractory to radioiodide (RAI) therapy. MAPK pathway inhibitors rescue thyroid-differentiated proper...
Kaydedildi:
| Yayımlandı: | Endocr Relat Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Bioscientifica Ltd
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8183640/ https://ncbi.nlm.nih.gov/pubmed/33890869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-21-0017 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|